Novartis India: Stable Promoter Stake, Major Insider Sell

By ThePip DeskNovartis India: Stable Promoter Stake, Major Insider Sell

Novartis India maintains a steady 70.68% promoter stake while Novartis AG executes a significant insider share sale in July 2026. Market analysis inside.

Novartis India Ltd. maintained a consistent shareholding structure for its foreign promoter, Novartis AG, at 70.68% between June 2025 and June 2026, alongside a notable insider sell transaction observed in July 2026.

Consistent Promoter Holding

The foreign promoter, Novartis AG, demonstrated stable ownership across all reported quarters. This consistent stake highlights a firm commitment from the parent entity during the specified period.

  • Foreign Promoter (Novartis AG): 70.68% (consistent across all quarters)
  • Domestic Institutional Investors (DIIs) (June 2026): 0.66%
  • Foreign Institutional Investors (FIIs) (June 2026): 0.16%

Domestic Institutional Investors and Foreign Institutional Investors held modest stakes in the company as of June 2026. Specific mutual funds also made notable investments during this period.

  • HDFC Mutual Fund (June 2026): 0.471%
  • Bandhan Mutual Fund (June 2026): 0.183%
  • Atul Limited (stake over 1%): 1.52%

Significant Insider Transaction

A substantial insider trade was recorded on July 29, 2026, involving Novartis AG. This transaction represents a significant movement of shares by the foreign promoter.

  • Seller: Novartis AG
  • Date: July 29, 2026
  • Shares Sold: 1,74,50,680
  • Price Per Share: ₹1,595.90
  • Total Value: ₹2,78,495.40 Lakh

This detailed shareholding analysis and the recent major insider transaction provide clear data points regarding the ownership dynamics of Novartis India Ltd.

    Novartis India: Stable Promoter Stake, Major Insider Sell | ThePip